Balance Sheet
Cash Flow Statement
AmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for MediWound (MDWD) over the last 13 years, with Q3 2025 value amounting to -$1.0 million.

  • MediWound's Capital Expenditures rose 1233.22% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.9 million, marking a year-over-year decrease of 17347.68%. This contributed to the annual value of -$6.3 million for FY2024, which is 19704.52% down from last year.
  • Latest data reveals that MediWound reported Capital Expenditures of -$1.0 million as of Q3 2025, which was up 1233.22% from -$1.0 million recorded in Q2 2025.
  • In the past 5 years, MediWound's Capital Expenditures ranged from a high of $10.7 million in Q4 2023 and a low of -$3.0 million during Q2 2024
  • In the last 5 years, MediWound's Capital Expenditures had a median value of -$1.0 million in 2025 and averaged -$220000.0.
  • Its Capital Expenditures has fluctuated over the past 5 years, first soared by 7400.0% in 2021, then tumbled by 84062.5% in 2023.
  • Quarter analysis of 5 years shows MediWound's Capital Expenditures stood at -$116000.0 in 2021, then decreased by 18.97% to -$138000.0 in 2022, then surged by 7867.39% to $10.7 million in 2023, then plummeted by 107.52% to -$806000.0 in 2024, then decreased by 29.65% to -$1.0 million in 2025.
  • Its Capital Expenditures was -$1.0 million in Q3 2025, compared to -$1.0 million in Q2 2025 and -$959000.0 in Q1 2025.